ArticleBlood advances2020

Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells.

Emi Ikebe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.